Intrathecal medicines
30 results
Applied filters
Trastuzumab: informing intrathecal risk assessment
18 April 2026Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Hydrocortisone: informing intrathecal risk assessment
18 April 2026Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Hydromorphone: informing intrathecal risk assessment
18 April 2026Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Thiotepa: informing intrathecal risk assessment
18 April 2026Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Topotecan: informing intrathecal risk assessment
18 April 2026Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Morphine: informing intrathecal risk assessment
18 April 2026Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Rituximab: informing intrathecal risk assessment
18 April 2026Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Amikacin: informing intrathecal risk assessment
18 April 2026Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Etoposide: informing intrathecal risk assessment
18 April 2026Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Levobupivacaine: informing intrathecal risk assessment
18 April 2026Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration